U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H25NO.ClH
Molecular Weight 331.88
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORMETHADONE HYDROCHLORIDE

SMILES

Cl.CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=GYWUCVKLUKFJLC-UHFFFAOYSA-N
InChI=1S/C20H25NO.ClH/c1-4-19(22)20(15-16-21(2)3,17-11-7-5-8-12-17)18-13-9-6-10-14-18;/h5-14H,4,15-16H2,1-3H3;1H

HIDE SMILES / InChI

Description

Normethadone is a derivate of opioid analgetic methadone, used as component of antitussive drops in Canada. Illicit drug.

CNS Activity

CNS Active
4002

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
Mu-type opioid receptor
61
Target ID: P33535|||Q64064
Gene ID: 25601.0
Gene Symbol: Oprm1
Target Organism: Rattus norvegicus (Rat)
Agonist
2752
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8583
Cophylac

Approved Use

Cough
Doses

Doses

DosePopulationAdverse events​
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Disc. AE: Hyporeflexia, Coma...
AEs leading to
discontinuation/dose reduction:
Hyporeflexia
Coma
Fever
Disseminated intravascular coagulation
Hepatocellular injury
Renal failure (grade 1)
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
15 drop 2 times / day multiple, oral
Recommended
Dose: 15 drop, 2 times / day
Route: oral
Route: multiple
Dose: 15 drop, 2 times / day
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
unhealthy, CHILD|ADOLESCENT|ADULT
Health Status: unhealthy
Age Group: CHILD|ADOLESCENT|ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
Disc. AE: Opioid abuse, Opioid type dependence...
AEs leading to
discontinuation/dose reduction:
Opioid abuse
Opioid type dependence
Respiratory depression (grade 3-5)
Neonatal opioid withdrawal syndrome (grade 4)
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
AEs

AEs

AESignificanceDosePopulation
Coma Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Disseminated intravascular coagulation Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Fever Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Hepatocellular injury Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Hyporeflexia Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Renal failure grade 1
Disc. AE
100 mg single, oral
Overdose
Dose: 100 mg
Route: oral
Route: single
Dose: 100 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
healthy, CHILD
Health Status: healthy
Age Group: CHILD
Sex: M
Food Status: UNKNOWN
Sources:
https://pubmed.ncbi.nlm.nih.gov/6481543/
Opioid abuse Disc. AE
15 drop 2 times / day multiple, oral
Recommended
Dose: 15 drop, 2 times / day
Route: oral
Route: multiple
Dose: 15 drop, 2 times / day
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
unhealthy, CHILD|ADOLESCENT|ADULT
Health Status: unhealthy
Age Group: CHILD|ADOLESCENT|ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
Opioid type dependence Disc. AE
15 drop 2 times / day multiple, oral
Recommended
Dose: 15 drop, 2 times / day
Route: oral
Route: multiple
Dose: 15 drop, 2 times / day
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
unhealthy, CHILD|ADOLESCENT|ADULT
Health Status: unhealthy
Age Group: CHILD|ADOLESCENT|ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
Respiratory depression grade 3-5
Disc. AE
15 drop 2 times / day multiple, oral
Recommended
Dose: 15 drop, 2 times / day
Route: oral
Route: multiple
Dose: 15 drop, 2 times / day
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
unhealthy, CHILD|ADOLESCENT|ADULT
Health Status: unhealthy
Age Group: CHILD|ADOLESCENT|ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
Neonatal opioid withdrawal syndrome grade 4
Disc. AE
15 drop 2 times / day multiple, oral
Recommended
Dose: 15 drop, 2 times / day
Route: oral
Route: multiple
Dose: 15 drop, 2 times / day
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
unhealthy, CHILD|ADOLESCENT|ADULT
Health Status: unhealthy
Age Group: CHILD|ADOLESCENT|ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
https://pdf.hres.ca/dpd_pm/00045654.PDF
PubMed

PubMed

TitleDatePubMed
Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry.
2009-04-15
Phenyl-substituted normethadones: synthesis and pharmacology.
1995-03

Sample Use Guides

In Vivo Use Guide
Cophylac (normethadone HCl 10 mg and p-hydroxyephedrine HCl 20 mg): 15 drops twice daily
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
COPHYLAC COMPONENT NORMETHADONE HYDROCHLORIDE
Preferred Name English
NORMETHADONE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
ISOAMIDONE I HYDROCHLORIDE
Common Name English
NORMETHADONE HYDROCHLORIDE [MI]
Common Name English
Normethadone hydrochloride [WHO-DD]
Common Name English
UM 118
Code English
DACARTIL HYDROCHLORIDE
Common Name English
3-HEXANONE, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, HYDROCHLORIDE
Systematic Name English
NIH-10385
Code English
6-DIMETHYLAMINO-4,4-DIPHENYLHEXAN-3-ONE HYDROCHLORIDE
Systematic Name English
NORMETHADONE HYDROCHLORIDE [MART.]
Common Name English
DESMETHYLMETHADONE HYDROCHLORIDE
Common Name English
TICARDA
Brand Name English
MCV-4457
Code English
Code System Code Type Description
EVMPD
SUB03461MIG
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
DRUG BANK
DBSALT001919
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
PUBCHEM
13312
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
EPA CompTox
DTXSID60233711
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
ECHA (EC/EINECS)
212-694-4
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
MESH
C005845
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
SMS_ID
100000085723
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
MERCK INDEX
m8068
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY Merck Index
CAS
847-84-7
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
FDA UNII
OIV53II16G
Created by admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of NORMETHADONE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966